Moderna, Inc. SEC filings MRNA
Moderna, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Mar 30, 2021. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 31, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Mar 16, 2026 | — |
| DEF 14A | Proxy statement | Mar 16, 2026 | May 6, 2026 |
| DEFA14A | Additional proxy material | Oct 20, 2025 | — |
| DEF 14A | Proxy statement | Oct 15, 2025 | Nov 12, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 3, 2025 | Nov 12, 2025 |
| DEFA14A | Additional proxy material | Mar 11, 2025 | — |
| DEF 14A | Proxy statement | Mar 11, 2025 | Apr 30, 2025 |
| DEFA14A | Additional proxy material | Mar 21, 2024 | — |
| DEF 14A | Proxy statement | Mar 21, 2024 | May 6, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 11, 2024 | May 6, 2024 |
| DEFA14A | Additional proxy material | Apr 14, 2023 | — |
| DEFA14A | Additional proxy material | Mar 15, 2023 | — |
| DEF 14A | Proxy statement | Mar 15, 2023 | — |
| DEFA14A | Additional proxy material | Mar 9, 2022 | — |
| DEF 14A | Proxy statement | Mar 9, 2022 | Apr 28, 2022 |
Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MRNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1682852
- Former names
- Moderna Therapeutics, Inc. (until Aug 24, 2016)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.